PRODUCT DATASHEET · DC82105
93-O17O
Version 1.c988bdd1 · 2026-09-13
| CAS No. | Not available |
| Chemical Name | 93-O17O |
| Synonyms | bis(2-(tetradecyloxy)ethyl) 3,3'-((3-(1H-imidazol-1-yl)propyl)azanediyl)dipropionate;93O17O， 93 O17O |
| SMILES | O=C(OCCOCCCCCCCCCCCCCC)CCN(CCCN1C=NC=C1)CCC(OCCOCCCCCCCCCCCCCC)=O |
| Formula | C44H83N3O6 |
| M.Wt | 750.2 |
| Purity | ELSD-HPLC>95% |
| Storage | Original product: up to 1 year under the storage conditions stated on the vial, kept tightly sealed. Stock solutions: aliquots at -20°C, generally up to one month. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | 1. Zhao, X., Chen, J., Qiu, M., et al. Imidazole-based synthetic lipidoids for in vivo mrna delivery into primary T lymphocytes. Angew. Chem. Int. Ed. Engl. 59(45), 20083-20089 (2020). 2. Chen, J., Qiu, M., Ye, Z., et al. In situ cancer vaccination using lipidoid nanoparticles. Sci. Adv. 7(19), eabf1244 (2021). 3. Li, Y., Yang, T., Yu, Y., et al. Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins. Biomaterials 178, 652-662 (2018). |
93-O17O is a chalcogen-containing ionizable cationic lipidoid. It has been used in the generation of lipid nanoparticles (LNPs). LNPs containing 93-O17O localize to the spleen after intravenous injection into mice.LNPs containing 93-O17O have been used for the delivery of Cre recombinase and ribonucleoproteins for genome editing in mice and for the intratumoral delivery of cGAMP to enhance cross-presentation of tumor antigens.
Specifications shown are product-page values, not batch test results.
Read Instructions for Use →